Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Malaria detectives track infections in burkina faso village

NCT ID NCT04650815

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how often people of all ages in Sabou, Burkina Faso, get malaria. Researchers checked 608 healthy volunteers monthly for a year, taking blood samples and asking about symptoms. They also collected mosquitoes from homes and did feeding experiments to understand transmission. The goal was to gather data that could help design future malaria vaccines.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

608 people

The number who actually took part.

Started

Jun 2021

Finished

Jun 2024

Lead sponsor

A government research agency

The lead sponsor is the US National Institutes of Health.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Up to 900 volunteers (ages 0.5 - 65 years) from Sabou Health District area will be recruited for this study.

Ages

6 months and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* HOUSEHOLD INCLUSION CRITERIA: In order to be included in the study, households must meet all of the following inclusion criteria: * Household with at least 3 residents eligible for participation. * Household with at least one compound member who is below 5 years of age whose parents or caretakers are willing to provide informed consent for the child to participate * Household with at least one compound member aged 5-15 years whose parents or caretakers are willing to provide informed consent for the child to participate * Household members willing to accommodate mosquito sampling in their compound, both indoors and outdoors. SUBJECT INCLUSION CRITERIA: * 0.5 to 65 years of age * Known resident within the study area and planning to remain for the duration of the study * Acceptance and signature of the written informed consent and the assent for children aged 12-19 years who are not otherwise emancipated SUBJECT EXCLUSION CRITERIA: * Major congenital defect diagnosed based on medical history and examination * Behavioral, cognitive, or psychiatric disease that in the opinion of the investigator affects the ability of the subject to understand and cooperate with the study protocol. * Other condition that, in the opinion of the investigator, would jeopardize the safety or rights of a volunteer participating in the trial or would render the subject unable to comply with the protocol. * Current participation in malaria vaccine trials or participation in such trials in the last 2 years

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Malaria are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Infections malaria

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CMAMK

    Sabou, Burkina Faso

  • GRAS

    Sabou, Burkina Faso

More trials for these conditions

Other studies related to the condition(s) this trial covers.